MustGrow Biologics's total assets for Q4 2024 were C$5.42M, an increase of 25.58% from the previous quarter. TSE:MGRO total liabilities were C$3.25M for the fiscal quarter, a 244.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.